Case #2: A 60-Year-Old Type 2 Diabetic Woman with MASH and F3 Liver Fibrosis This Ace the Case activity will review a detailed case discussion on the latest clinical care guidelines and emerging treatments for MASH. Participants will explore novel treatment targets and the most recent clinical data for treating patients with MASH and cardiometabolic comorbidities. Gain practical insights for individualizing patient care plans in your practice. Don’t miss this opportunity to enhance your expertise and improve patient outcomes

Case #1:  A 37-Year-Old Man with Incidental Hepatic Steatosis on Abdominal Ultrasound During this Ace the Case activity, you will learn about risk factors for metabolic dysfunction–associated steatotic liver disease (MASLD), metabolic dysfunction–associated steatohepatitis (MASH), and advanced fibrosis, as well as the current and emerging noninvasive liver assessment tests.

This three part series consists of 3 cases that illustrate important concepts in managing patients with familial hypercholesterolemia, patients with hyperlipidemia and cardiometabolic comorbidities, and patient with South Asian descent with increased risk of ASCVD and a history of percutaneous Intervention. The cases are designed to be quick and offer high-level takeaways and pearls.   In this podcast, experts will discuss the following case: A 54-Year-Old South Asian Male with a History of Cardiac Percutaneous Intervention

This three part series consists of 3 cases that illustrate important concepts in managing patients with familial hypercholesterolemia, patients with hyperlipidemia and cardiometabolic comorbidities, and patient with South Asian descent with increased risk of ASCVD and a history of percutaneous Intervention. The cases are designed to be quick and offer high-level takeaways and pearls.   In this podcast, experts will discuss the following case: A 62-Year-Old Diabetic Woman with an LDL-C of 53 mg/dL

This three part series consists of 3 cases that illustrate important concepts in managing patients with familial hypercholesterolemia, patients with hyperlipidemia and cardiometabolic comorbidities, and patient with South Asian descent with increased risk of ASCVD and a history of percutaneous Intervention. The cases are designed to be quick and offer high-level takeaways and pearls.   In this podcast, experts will discuss the following case: A 34-Year-Old Woman with Severe Heterozygous Familial Hypercholesterolemia (HeFH)

Tune in to hear our esteemed faculty members, Drs. Morris and Somers, delve into topics such as defining poor sleep, assessing sleep health in patients, and exploring the connection between sleep disorders and cardiometabolic health.  Recorded Saturday, April 20, 2024.

A stimulating conversation between our co-chair Pamela Morris, MD and Michelle W. Chestovich, MD, a famous physician life coach on resiliency and physician burn-out.   Recorded Friday, April 19 2024. https://www.cardiometabolichealth.org/

Pamela B. Morris, MD and Erica Spatz, MD, MHS discuss the association of Depression and Poor Mental Health With Cardiovascular Disease, particularly in women. Recorded April 18, 2024.   www.cardiometabolichealth.org

In this conversation with CMHC Senior Planning Committee Member Pam Taub, MD, future leaders Courtney Bess, MD, MS and Aarthi Thakkar, MD, MPH discuss gaps in current fellowship training in cardiometabolic health, how being part of this program and attending CMHC events has helped them in their training, as well as important takeaways they have been able to apply to patient care.

Future leaders in cardiometabolic health Revathy Sampath-Kumar, MD and L. Nedda Dastmalchi, DO discuss how being part of this program and attending a CMHC event has helped them in their career, in a conversation with CMHC's Senior Planning Committee Member Pam Taub, MD.